ExodusPoint Capital Management’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.9M | Buy |
+128,157
| New | +$1.9M | 0.02% | 711 |
|
|
2024
Q1 | – | Sell |
-37,419
| Closed | -$336K | – | 1848 |
|
|
2023
Q4 | $336K | Buy |
+37,419
| New | +$336K | ﹤0.01% | 1074 |
|
|
2023
Q3 | – | Sell |
-396,060
| Closed | -$6.08M | – | 2071 |
|
|
2023
Q2 | $6.08M | Buy |
+396,060
| New | +$6.08M | 0.05% | 335 |
|
|
2023
Q1 | – | Sell |
-163,993
| Closed | -$3.45M | – | 2037 |
|
|
2022
Q4 | $3.45M | Buy |
+163,993
| New | +$3.45M | 0.05% | 437 |
|
|
2022
Q1 | – | Sell |
-39,120
| Closed | -$1.21M | – | 2619 |
|
|
2021
Q4 | $1.21M | Buy |
+39,120
| New | +$1.21M | 0.01% | 931 |
|
|
2021
Q1 | – | Sell |
-7,372
| Closed | -$201K | – | 2549 |
|
|
2020
Q4 | $201K | Buy |
+7,372
| New | +$201K | ﹤0.01% | 1659 |
|
|
2020
Q1 | – | Sell |
-18,815
| Closed | -$267K | – | 1588 |
|
|
2019
Q4 | $267K | Buy |
18,815
+7,262
| +63% | +$103K | 0.01% | 1154 |
|
|
2019
Q3 | $134K | Buy |
+11,553
| New | +$134K | ﹤0.01% | 1172 |
|